Frank Angella

Frank is a Managing Partner of GroveStreet and a member of the firm’s Investment Committee. He is responsible for a number of our client relationships and leads fund and direct investments across all segments of private equity and venture capital in the US and Europe including healthcare venture capital. Frank is also a guest lecturer in the Harvard MBA class Venture Capital and Private Equity. Prior to GroveStreet, Frank was a co-founder of Biocode Inc., a venture-backed biotech start-up where he helped raise $15 million in venture capital over three rounds of financing. During his six-year tenure at Biocode, Frank played a number of executive roles, including 18 months as Managing Director, Asia, based in Singapore and was a co-inventor on two patents. Previously, Frank was an Associate at Innotage Management, an early stage venture investment group, and was an Analyst in the healthcare group of Advent Venture Partners in London.